Alyeska Investment Group, L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for Immunic, Inc. Common Stock, $0.0001 par value (IMUX)

Filing Manager
Alyeska Investment Group, L.P.
Reporting Manager
Alyeska Investment Group, L.P.
Security
Immunic, Inc. Common Stock, $0.0001 par value
Symbol
IMUX
Shares outstanding
120,192,308 shares
Disclosed Ownership
7,500,000 shares
Ownership
6.2%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:41:29 UTC
Date of event
31 Dec 2025
Previous filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Alyeska Investment Group, L.P. 6.2% 7,500,000 0 7,500,000 Jason Bragg Jason Bragg | Chief Financial Officer
Alyeska Fund GP, LLC 6.2% 7,500,000 0 7,500,000 Jason Bragg Jason Bragg | Chief Financial Officer
Anand Parekh 6.2% 7,500,000 0 7,500,000 Anand Parekh Anand Parekh | Self